Work

MPN-1200: Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets ≥50 × 109/L at Initiation (TRIPAC)

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02405-5

Authors: Ghaith Abu-Zeinah, Alex Coltoff, Erick Moyneur, Katherine Dea, Michael Marrone, Sara Bruce Wirta, Faizan Sattar, Michael Vredenburg, Andrew Srisuwananukorn

Institutions: Weill Cornell Medicine, Medical University of South Carolina, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204723532

Cites:

Cited by:

Related to: 10